GemPharmatech Co (SHSE:688046) Forward Dividend Yield %: 0.95% (As of Jul. 04, 2026)


SHSE:688046 GemPharmatech Co Ltd SHSE:688046
95 GF Score
Price ¥23.22
GF Value ¥19.45
Valuation Modestly Overvalued
! 8 Warning Signs
View Full Analysis

What is GemPharmatech Co Forward Dividend Yield %?

GemPharmatech Co SHSE:688046 -1.61% 95 Forward Dividend Yield % is 0.95% as of Jul. 04, 2026. GuruFocus rates SHSE:688046 with a GF Score™ of 95/100 and a GF Value™ of ¥19.45 (Modestly Overvalued). The stock has 8 warning signs investors should review. Among 149 Biotechnology companies, GemPharmatech Co ranks worse than 65.77% on this metric.

As of today (2026-07-04), the Forward Annual Dividend Yield of GemPharmatech Co is 0.95%.

As of today (2026-07-04), the Trailing Annual Dividend Yield of GemPharmatech Co is 0.95%.

SHSE:688046's Forward Dividend Yield % is ranked worse than
65.77% of 149 companies
in the Biotechnology industry
Industry Median: 1.27 vs SHSE:688046: 0.95

GemPharmatech Co's Dividends per Share for the three months ended in Mar. 2026 was ¥0.00.

During the past 12 months, GemPharmatech Co's average Dividends Per Share Growth Rate was -26.30% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


GemPharmatech Co  (SHSE:688046) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


GemPharmatech Co Forward Dividend Yield % Related Terms


SHSE:688046 vs VRTX, REGN, ALNY: Forward Dividend Yield % Comparison

For the Biotechnology subindustry, GemPharmatech Co's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GemPharmatech Co Forward Dividend Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, GemPharmatech Co's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where GemPharmatech Co's Forward Dividend Yield % falls into.


SHSE:688046
95GF Score
GemPharmatech Co Ltd SHSE:688046
Forward Dividend Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

GemPharmatech Co Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

GemPharmatech Co Recent Full-Year* Dividend History

Amount Ex-date Record Date Pay Date Type Frequency Forex Rate
CNY 0.1900002026-06-092026-06-082026-06-09Cash Dividendsemi-annuallyCNY:CNY 1.000000
CNY 0.0300002025-11-202025-11-192025-11-20Cash Dividendsemi-annuallyCNY:CNY 1.000000
CNY 0.1100002025-07-112025-07-102025-07-11Cash Dividendsemi-annuallyCNY:CNY 1.000000

* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.

GemPharmatech Co's Forward Annual Dividend Yield (%) for Today is calculated as

Forward Annual Dividend Yield=Forward Full Year Dividend/Current Share Price
=0.38/23.22
=1.64 %

Current Share Price is ¥23.22.
GemPharmatech Co's Dividends per Share for the forward twelve months is calculated as ¥0.19 * 2 = ¥0.38.

GemPharmatech Co's Trailing Annual Dividend Yield (%) for Today is calculated as

Trailing Annual Dividend Yield=Most Recent Full Year Dividend/Current Share Price
=0.33/23.22
=1.42 %

Current Share Price is ¥23.22.
GemPharmatech Co's Dividends per Share for the trailing twelve months (TTM) ended in Today is ¥0.33.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Forward Dividend Yield % of 0.95% mean?
GemPharmatech Co (SHSE:688046) has a Forward Dividend Yield % of 0.95% as of Jul. 04, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on GemPharmatech Co and its competitors. According to the industry distribution chart, GemPharmatech Co ranks #98 out of 149 companies in the Biotechnology industry, placing it in the top 65.8%.
Is GemPharmatech Co's Forward Dividend Yield % too high?
GemPharmatech Co's current Forward Dividend Yield % is 0.95%. The Biotechnology industry median Forward Dividend Yield % is 1.27. GemPharmatech Co's value of 0.95% is 25.2% below this industry median. Based on the distribution chart, GemPharmatech Co ranks #98 out of 149 companies in the Biotechnology industry, which is below the industry midpoint. Overall, GemPharmatech Co has a GF Score™ of 95/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does GemPharmatech Co's Forward Dividend Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, GemPharmatech Co ranks #98 out of 149 companies for Forward Dividend Yield %. This places GemPharmatech Co in the lower half of its industry. The industry median Forward Dividend Yield % is 1.27. GemPharmatech Co's value of 0.95% is 25.2% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Biotechnology company?
The median Forward Dividend Yield % among Biotechnology companies is 1.27, based on 149 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. GemPharmatech Co's current Forward Dividend Yield % of 0.95% is 25.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on GemPharmatech Co and its competitors. For the Biotechnology industry, the median Forward Dividend Yield % is 1.27 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. GemPharmatech Co's current Forward Dividend Yield % is 0.95%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GemPharmatech Co stock overvalued right now?
Based on GuruFocus' analysis, GemPharmatech Co (SHSE:688046) is currently considered Modestly Overvalued. The stock's GF Value™ is ¥19.45, compared to a current price of ¥23.22 — trading 19.4% above its estimated fair value. The current Forward Dividend Yield % is 0.95% and 25.2% below the Biotechnology industry median of 1.27. GemPharmatech Co's overall GF Score™ is 95/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For GemPharmatech Co (SHSE:688046), the current Forward Dividend Yield % is 0.95% as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is GemPharmatech Co (SHSE:688046) Overvalued in 2026?

Based on GuruFocus' analysis, GemPharmatech Co stock appears to be overvalued. The current stock price of ¥23.22 is trading 19.4% above its estimated GF Value™ of ¥19.45. GuruFocus considers GemPharmatech Co to be Modestly Overvalued.

Key valuation signals for SHSE:688046:

  • Forward Dividend Yield %: 0.95%
  • GF Value™: ¥19.45 vs. price of ¥23.22 (19.4% above fair value)
  • GF Score™: 95/100 with 8 warning signs
  • Industry Position: 25.2% below the Biotechnology median (#98 of 149)

No single metric tells the full story. See the SHSE:688046 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


GemPharmatech Co Business Description

Address No. 12, Xuefu Road, Jiangbei New District, Jiangsu Province, Nanjing, CHN, 210032
GemPharmatech Co Ltd is a provider of genetically engineered mouse models and services to preclinical research and development communities. The company develops mouse models with independent intellectual property rights based on technical platforms such as gene editing, stem cells, phenotypic analysis, efficacy analysis, and sterile animals, and carries out one-stop services such as model customization, customized breeding, and functional efficacy analysis.
95GF Score

Get the complete analysis for SHSE:688046

Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥23.22
Price
¥19.45
GF Value